Once-daily Fluticasone Furoate Nasal Spray Showed Greater Improvement In Nocturnal Quality Of Life In Subjects With Seasonal Allergic Rhinitis Compared With Oral Fexofenadine

Once-daily Fluticasone Furoate Nasal Spray Showed Greater Improvement In Nocturnal Quality Of Life In Subjects With Seasonal Allergic Rhinitis Compared With Oral Fexofenadine

Rationale Fluticasone Furoate Nasal Spray (FFNS), a new enhanced-affinity intranasal corticosteroid, was evaluated against oral fexofenadine (FEX) using the Nocturnal Rhinoconjunctivitis Quality of Life Questionnaire (NRQLQ) to further characterize its therapeutic profile.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2008-02, Vol.121 (2), p.S53-S53
Hauptverfasser: Andrews, C.P, Martin, B.G, Jacobs, R.L, Diaz, J, Toler, W.T, Prillaman, B.A, Dalal, A.A, Philpot, E.E
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Allergy and Immunology
Quality of life
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Rationale Fluticasone Furoate Nasal Spray (FFNS), a new enhanced-affinity intranasal corticosteroid, was evaluated against oral fexofenadine (FEX) using the Nocturnal Rhinoconjunctivitis Quality of Life Questionnaire (NRQLQ) to further characterize its therapeutic profile.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2007.12.216